 |
PDBsum entry 2d1j
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Design, Synthesis, And biological activity of non-Basic compounds as factor xa inhibitors: sar study of s1 and aryl binding sites.
|
 |
|
Authors
|
 |
S.Komoriya,
N.Haginoya,
S.Kobayashi,
T.Nagata,
A.Mochizuki,
M.Suzuki,
T.Yoshino,
H.Horino,
T.Nagahara,
M.Suzuki,
Y.Isobe,
T.Furugoori.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2005,
13,
3927-3954.
|
 |
|
PubMed id
|
 |
|
 |
|
Note: In the PDB file this reference is
annotated as "TO BE PUBLISHED". The citation details given above have
been manually determined.
|
 |
 |
|
Abstract
|
 |
|
Compound 7 was identified as the active metabolite of 6 by HPLC and mass
spectral analysis. Modification of lead compound 7 by transformation of its
N-oxide 6-6 biaryl ring system and fused aromatics produced a series of
non-basic fXa inhibitors with excellent potency in anti-fXa and anticoagulant
assays. The optimized compounds 73b and 75b showed sub to one digit micromolar
anticoagulant activity (PTCT2). Particularly, anti-fXa activity was detected in
plasma of rats orally administered with 1mg/kg of compound 75b.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Design, Synthesis, And biological activity of non-Basic compounds as factor xa inhibitors: sar study of s1 and aryl binding sites.
|
 |
|
Authors
|
 |
S.Komoriya,
N.Haginoya,
S.Kobayashi,
T.Nagata,
A.Mochizuki,
M.Suzuki,
T.Yoshino,
H.Horino,
T.Nagahara,
M.Suzuki,
Y.Isobe,
T.Furugoori.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2005,
13,
3927-3954.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
Synthesis and conformational analysis of a non-Amidine factor xa inhibitor that incorporates 5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-C]pyridine as s4 binding element.
|
 |
|
Authors
|
 |
N.Haginoya,
S.Kobayashi,
S.Komoriya,
T.Yoshino,
M.Suzuki,
T.Shimada,
K.Watanabe,
Y.Hirokawa,
T.Furugori,
T.Nagahara.
|
 |
|
Ref.
|
 |
J Med Chem, 2004,
47,
5167-5182.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
|
|
|
 |